Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
2.880
+0.030 (1.05%)
Apr 9, 2026, 1:43 PM EDT - Market open

LIXT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
333555816
Market Cap Growth
829.44%656.56%-13.62%-37.74%-48.10%-58.39%
Enterprise Value
29.0432.917.034.586.6415.03
Last Close Price
2.883.932.032.355.1011.90
PE Ratio
--3.12-1.28-0.88-1.28-2.38
PB Ratio
3.163.575.521.321.643.41
P/TBV Ratio
1.441.975.521.131.563.35
P/FCF Ratio
--11.26-1.41-1.23-1.84-3.95
P/OCF Ratio
--11.26-1.41-1.23-1.84-3.95
EV/EBITDA Ratio
--6.44-1.97-0.90-1.05-2.24
EV/EBIT Ratio
--6.44-1.97-0.90-1.05-2.24
EV/FCF Ratio
--10.73-2.17-1.07-1.44-3.63
Debt / Equity Ratio
0.050.050000
Debt / EBITDA Ratio
-0.20-0.20----
Debt / FCF Ratio
-0.25-0.34----
Net Debt / Equity Ratio
-0.42-0.42-1.26-1.05-1.04-1.01
Net Debt / EBITDA Ratio
0.800.800.290.830.850.72
Net Debt / FCF Ratio
1.001.330.320.981.161.16
Quick Ratio
3.833.833.2613.3913.5315.92
Current Ratio
3.883.883.6013.7314.0516.81
Return on Equity (ROE)
-114.56%-114.56%-148.73%-111.07%-126.81%-137.28%
Return on Assets (ROA)
-73.60%-73.60%-131.01%-103.15%-118.48%-130.22%
Return on Invested Capital (ROIC)
-141.61%-141.61%25266.36%13615.90%-61843.92%-107777.16%
Return on Capital Employed (ROCE)
-83.54%-83.54%-148.19%-111.14%-126.79%-137.12%
Earnings Yield
-18.36%-32.06%-78.33%-113.19%-78.24%-42.02%
FCF Yield
-9.56%-8.88%-71.01%-81.22%-54.32%-25.33%
Buyback Yield / Dilution
-115.21%-115.21%-17.41%-21.10%-17.41%-19.48%
Total Shareholder Return
-115.21%-115.21%-17.41%-21.10%-17.41%-19.48%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q